{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T11:42:09Z","timestamp":1784806929286,"version":"3.55.0"},"reference-count":47,"publisher":"Impact Journals, LLC","issue":"73","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,9,18]]},"DOI":"10.18632\/oncotarget.26107","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T14:36:35Z","timestamp":1537281395000},"page":"33818-33831","source":"Crossref","is-referenced-by-count":28,"title":["Mitochondria as oncotarget: a comparison between the tetracycline analogs doxycycline and COL-3"],"prefix":"10.18632","volume":"9","author":[{"given":"Margherita","family":"Protasoni","sequence":"first","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, NW3 2PF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert M.","family":"Kroon","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, NW3 2PF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem","family":"Taanman","sequence":"additional","affiliation":[{"name":"Department of Clinical and Movement Neurosciences, Institute of Neurology, University College London, London, NW3 2PF, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2018,9,18]]},"reference":[{"key":"1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/bip.10410","article-title":"Chemical and functional diversity of small molecule ligands for RNA","volume":"70","author":"Hermann","year":"2003","journal-title":"Biopolymers"},{"key":"2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1093\/jac\/dkl224","article-title":"Pharmacokinetics and pharmacodynamics of the tetracyclines including glycylcyclines","volume":"58","author":"MacGowan","year":"2006","journal-title":"J Antimicrob Chemother"},{"key":"3","doi-asserted-by":"crossref","unstructured":"Kroon, van den Bogert. The mitochondrial genome as a target for chemotherapy of cancer. Quagliarriello (ed.), Slater (ed.), Palmieri (ed.), Saccone (ed.), Kroon (ed.). Achievements and perspectives of mitochondrial research 2, 21-33; 1985, Elsevier, Amsterdam.","DOI":"10.1016\/S0304-3835(84)80023-3"},{"key":"4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/0304-3835(86)90037-6","article-title":"Inhibition of mitochondrial protein synthesis leads to proliferation arrest in the G-phase of the cell cycle","volume":"32","author":"Kroon","year":"1986","journal-title":"Cancer Lett"},{"key":"5","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/ijc.21447","article-title":"Tetracycline analogues (doxycycline and COL-3) induce caspase-dependent and -independent apoptosis in human colon cancer cells","volume":"118","author":"Nagasue","year":"2006","journal-title":"Int J Cancer"},{"key":"6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/ijc.22303","article-title":"Doxycycline induces caspase-dependent apoptosis in human pancreatic cancer cells","volume":"120","author":"Dalgleish","year":"2007","journal-title":"Int J Cancer"},{"key":"7","first-page":"3995","article-title":"Doxycycline induces apoptosis in PANC-1 pancreatic cancer cells","volume":"29","author":"Yanaga","year":"2009","journal-title":"Anticancer Res"},{"key":"8","doi-asserted-by":"crossref","first-page":"e114457","DOI":"10.1371\/journal.pone.0114457","article-title":"Cytotoxic effects of tetracycline analogues (doxycycline, minocycline and COL-3) in acute myeloid leukemia HL-60 cells","volume":"9","author":"Potacova","year":"2014","journal-title":"PLoS One"},{"key":"9","doi-asserted-by":"publisher","first-page":"67269","DOI":"10.18632\/oncotarget.18428","article-title":"Vitamin C and doxycycline: A synthetic lethal combination therapy targeting metabolic flexibility in cancer stem cells (CSCs)","volume":"8","author":"Lisanti","year":"2017","journal-title":"Oncotarget"},{"key":"10","first-page":"1000134","article-title":"Mitochondria and cancer: the Warburg fact","volume":"3","author":"Taanman","year":"2014","journal-title":"Chemotherapy: Open Access"},{"key":"11","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/jnci\/93.3.178","article-title":"Development of matrix metalloproteinase inhibitors in cancer therapy","volume":"93","author":"Eckhardt","year":"2001","journal-title":"J Natl Cancer Inst"},{"key":"12","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1177\/00220345870660080401","article-title":"A non-antibacterial chemically-modified tetracycline inhibits mammalian collagenase activity","volume":"66","author":"Ramamurthy","year":"1987","journal-title":"J Dent Res"},{"key":"13","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1177\/10454411910020030201","article-title":"Tetracyclines inhibit connective tissue breakdown: new therapeutic implications for an old family of drugs","volume":"2","author":"Rifkin","year":"1991","journal-title":"Crit Rev Oral Biol Med"},{"key":"14","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1128\/AAC.38.4.637","article-title":"Tetracycline analogs whose primary target is not the bacterial ribosome","volume":"38","author":"Chopra","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"15","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1023\/A:1006588708131","article-title":"Chemically modified tetracyclines inhibit human melanoma cell invasion and metastasis","volume":"16","author":"Hendrix","year":"1998","journal-title":"Clin Exp Metastasis"},{"key":"16","first-page":"773","article-title":"Doxycycline and other tetracyclines in the treatment of bone metastasis","volume":"14","author":"Singh","year":"2003","journal-title":"Anticancer Drugs"},{"key":"17","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.phrs.2010.11.003","article-title":"Chemically modified non-antimicrobial tetracyclines are multifunctional drugs against advanced cancers","volume":"63","author":"Lokeshwar","year":"2011","journal-title":"Pharmacol Res"},{"key":"18","first-page":"153","article-title":"Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi\u2019s sarcoma: a phase I AIDS Malignancy Consortium study","volume":"20","author":"Dezube","year":"2002","journal-title":"J Clin Oncol"},{"key":"19","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1200\/JCO.2005.04.2614","article-title":"Randomized phase II trial of matrix metalloproteinase inhibitor COL-3 in AIDS-related Kaposi\u2019s sarcoma: an AIDS Malignancy Consortium study","volume":"24","author":"Aboulafia","year":"2006","journal-title":"J Clin Oncol"},{"key":"20","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/s11060-011-0602-9","article-title":"Phase I and pharmacokinetic study of COL-3 in patients with recurrent high-grade gliomas","volume":"105","author":"Grossman","year":"2011","journal-title":"J Neurooncol"},{"key":"21","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1200\/JCO.2001.19.2.584","article-title":"Phase I clinical trial of oral COL-3, a matrix metalloproteinase inhibitor, in patients with refractory metastatic cancer","volume":"19","author":"Reed","year":"2001","journal-title":"J Clin Oncol"},{"key":"22","doi-asserted-by":"crossref","first-page":"6512","DOI":"10.1158\/1078-0432.CCR-04-0804","article-title":"A phase I and pharmacokinetic study of Col-3 (Metastat), an oral tetracycline derivative with potent matrix metalloproteinase and antitumor properties","volume":"10","author":"Rowinsky","year":"2004","journal-title":"Clin Cancer Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.phrs.2010.10.008","article-title":"Antimicrobial and non-antimicrobial tetracyclines in human cancer trials","volume":"63","author":"Dezube","year":"2011","journal-title":"Pharmacol Res"},{"key":"24","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S0741-5214(00)90163-0","article-title":"Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms","volume":"31","author":"Thompson","year":"2000","journal-title":"J Vasc Surg"},{"key":"25","first-page":"2041","article-title":"Comment on \u201caneurysmal lesions of patients with abdominal aortic aneurysm contain clonally expanded T cells\u201d","volume":"193","author":"Taanman","year":"2014","journal-title":"J Immunol"},{"key":"26","doi-asserted-by":"crossref","first-page":"11178","DOI":"10.3390\/ijms160511178","article-title":"Clonal expansion of T cells in abdominal aortic aneurysm: a role for doxycycline as drug of choice?","volume":"16","author":"Taanman","year":"2015","journal-title":"Int J Mol Sci"},{"key":"27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/ijc.10168","article-title":"Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model","volume":"98","author":"Golub","year":"2002","journal-title":"Int J Cancer"},{"key":"28","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1128\/AAC.49.4.1622-1625.2005","article-title":"Pharmacokinetics of oral doxycycline during combination treatment of severe falciparum malaria","volume":"49","author":"White","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"29","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/jac\/dkx487","article-title":"The effect of measuring serum doxycycline concentrations on clinical outcomes during treatment of chronic Q fever","volume":"73","author":"Oosterheert","year":"2018","journal-title":"J Antimicrob Chemother"},{"key":"30","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1023\/A:1022638013825","article-title":"Human cytochrome c oxidase: structure, function, and deficiency","volume":"29","author":"Taanman","year":"1997","journal-title":"J Bioenerg Biomembr"},{"key":"31","doi-asserted-by":"crossref","first-page":"e1381","DOI":"10.1002\/wrna.1381","article-title":"Modulating splicing with small molecular inhibitors of the spliceosome","volume":"8","author":"Jurica","year":"2017","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0014-4827(88)90385-0","article-title":"Mitochondrial biogenesis and mitochondrial activity during the progression of the cell cycle of human leukemic cells","volume":"178","author":"Kroon","year":"1988","journal-title":"Exp Cell Res"},{"key":"33","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1093\/jac\/27.5.607","article-title":"The effects of minocycline and tetracycline on the mitotic response of human peripheral blood-lymphocytes","volume":"27","author":"Kearney","year":"1991","journal-title":"J Antimicrob Chemother"},{"key":"34","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.lab.2003.12.012","article-title":"Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells","volume":"143","author":"Nagasue","year":"2004","journal-title":"J Lab Clin Med"},{"key":"35","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/CAD.0b013e328362b1be","article-title":"Inhibitory impacts of chemically modified tetracycline-3 and underlying mechanism in human cervical cancer cells","volume":"24","author":"Fan","year":"2013","journal-title":"Anticancer Drugs"},{"key":"36","first-page":"327","article-title":"Effects of oxytetracycline onproliferation and differentiation of erythroid and lymphoid cells in the rat","volume":"50","author":"Kroon","year":"1982","journal-title":"Clin Exp Immunol"},{"key":"37","doi-asserted-by":"publisher","first-page":"14796","DOI":"10.18632\/oncotarget.4193","article-title":"Inhibition of COP9-signalosome (CSN) deneddylating activity and tumor growth of diffuse large B-cell lymphomas by doxycycline","volume":"6","author":"Shapiro","year":"2015","journal-title":"Oncotarget"},{"key":"38","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1128\/AAC.7.1.55","article-title":"Comparative effect of tetracycline and doxycycline on the occurrence of resistant Escherichia coli in the fecal flora","volume":"7","author":"Onderdonk","year":"1975","journal-title":"Antimicrob Agents Chemother"},{"key":"39","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1111\/j.1365-4632.2006.02946.x","article-title":"Tetracycline\/doxycycline-induced cutaneous depressed pigmentation","volume":"45","author":"Erdem","year":"2006","journal-title":"Int J Dermatol"},{"key":"40","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00000372-200208000-00012","article-title":"Cutaneous hyperpigmentation induced by doxycycline: histochemical and ultrastructural examination, laser microprobe mass analysis, and cathodoluminescence","volume":"24","author":"Metze","year":"2002","journal-title":"Am J Dermatopathol"},{"key":"41","first-page":"265","article-title":"Photo-onycholysis associated with the use of doxycycline","volume":"329","author":"van Puijenbroek","year":"2004","journal-title":"BMJ"},{"key":"42","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1093\/jnci\/51.5.1417","article-title":"cultivation of human tumors: establishment of cell lines derived from a series of solid tumors","volume":"51","author":"Parks","year":"1973","journal-title":"J Natl Cancer Inst"},{"key":"43","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/ijc.2910250507","article-title":"Human cell line (COLO 357) of metastatic pancreatic adenocarcinoma","volume":"25","author":"Gordon","year":"1980","journal-title":"Int J Cancer"},{"key":"44","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1002\/ijc.2910410221","article-title":"Biological characterization and oncogene expression in human colorectal carcinoma cell lines","volume":"41","author":"Lynch","year":"1988","journal-title":"Int J Cancer"},{"key":"45","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/0076-6879(95)60134-1","article-title":"Mammalian cytochrome-c oxidase: characterization of enzyme and immunological detection of subunits in tissue extracts and whole cells","volume":"260","author":"Taanman","year":"1995","journal-title":"Methods Enzymol"},{"key":"46","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0076-6879(67)10048-7","article-title":"Cytochrome oxidase from beef heart mitochondria","volume":"10","author":"Tzagoloff","year":"1967","journal-title":"Methods Enzymol"},{"key":"47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0076-6879(69)13005-0","article-title":"Citrate synthase","volume":"13","author":"Srere","year":"1969","journal-title":"Methods Enzymol"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26107","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T19:30:15Z","timestamp":1589052615000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.26107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,18]]},"references-count":47,"journal-issue":{"issue":"73","published-print":{"date-parts":[[2018,9,18]]}},"alternative-id":["26107","30333912"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.26107","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,18]]}}}